Evidence map›Paper›PMID 11046138›Full record

ArticleMolecular and cellular biology2000

CD28 and the tyrosine kinase lck stimulate mitogen-activated protein kinase activity in T cells via inhibition of the small G protein Rap1.

K D Carey, T J Dillon, J M Schmitt, A M Baird, A D Holdorf, D B Straus, A S Shaw, P J Stork

Abstract read
In one paragraph

Article in Molecular and cellular biology, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 82 citations in OpenAlex.

  1. Review
  2. CAR- and TRuC-redirected regulatory T cells differ in capacity to control adaptive immunity to FVIII.Molecular therapy : the journal of the American Society of Gene Therapy · 2021
    Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

K D CareyVollum Institute, Oregon Health Sciences University, Portland, Oregon 97201, USA.
T J Dillon
J M Schmitt
A M Baird
A D Holdorf
D B Straus
A S Shaw
P J Stork
Vollum Institute · USWashington University in St. Louis · USUniversity of Chicago · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Proliferation of T cells via activation of the T-cell receptor (TCR) requires concurrent engagement of accessory costimulatory molecules to achieve full activation. The best-studied costimulatory molecule, CD28, achieves these effects, in part, by augmenting signals from the TCR to the mitogen-activated protein (MAP) kinase cascade. We show here that TCR-mediated stimulation of MAP kinase extracellular-signal-regulated kinases (ERKs) is limited by activation of the Ras antagonist Rap1. CD28 increases ERK signaling by blocking Rap1 action. CD28 inhibits Rap1 activation because it selectively stimulates an extrinsic Rap1 GTPase activity. The ability of CD28 to stimulate Rap1 GTPase activity was dependent on the tyrosine kinase Lck. Our results suggest that CD28-mediated Rap1 GTPase-activating protein activation can help explain the augmentation of ERKs during CD28 costimulation.

Indexed as

AnimalsCD28 AntigensCD3 ComplexEnzyme ActivationEnzyme InhibitorsFlavonoidsHumansJurkat CellsLymphocyte Specific Protein Tyrosine Kinase p56(lck)MAP Kinase Signaling SystemMiceMice, Inbred C57BLMitogen-Activated Protein Kinase Kinasesrap1 GTP-Binding Proteinsras ProteinsReceptors, Antigen, T-Cell2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-oneCD28 AntigensCD3 ComplexEnzyme InhibitorsFlavonoidsLymphocyte Specific Protein Tyrosine Kinase p56(lck)Mitogen-Activated Protein Kinase Kinasesrap1 GTP-Binding Proteinsras ProteinsReceptors, Antigen, T-Cell

Identifiers

PMID11046138
PMCPMC102148
OpenAlexW2162388951

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.